Literature DB >> 22613008

Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.

Deok Sung Bae1, Yu Kyeong Hwang, Jae Kwon Lee.   

Abstract

In this study, we investigate the relationship between natural killer (NK) cell susceptibility and the surface markers of cancer cells. Through phenotypic analysis, we found evidence that more susceptible cancer cell lines (K562 and Jurkat) express more NKG2D ligands. Major histocompatibility complex (MHC) class I chain-related A/B (MIC-A/B) and UL16 binding protein (ULBP) 1-5 molecules are typical ligands of NKG2D. The high killing activity of NK cells against K562 was abolished through the addition of a NKG2D blocking antibody. Upon in vitro stimulation with quercetin, low susceptible cancer cells increased NKG2D ligand expression, leading to enhancement of NK cell cytolytic activity. These results suggested that the anti-cancer activity of NK cells is not dependent on the origin and growth style of the target cells, but is dependent on the surface markers of the target cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613008     DOI: 10.1016/j.cellimm.2012.04.011

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  19 in total

1.  Constitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expression.

Authors:  Neekun Sharma; Mary A Markiewicz
Journal:  Blood Adv       Date:  2019-05-28

2.  IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities.

Authors:  Sigrid Dubois; Kevin C Conlon; Jürgen R Müller; Jennifer Hsu-Albert; Nancy Beltran; Bonita R Bryant; Thomas A Waldmann
Journal:  Cancer Immunol Res       Date:  2017-08-25       Impact factor: 11.151

3.  Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer.

Authors:  Takahiro Nakajima; Hirokazu Okayama; Mai Ashizawa; Masaru Noda; Keita Aoto; Motonobu Saito; Tomoyuki Monma; Shinji Ohki; Masahiko Shibata; Seiichi Takenoshita; Koji Kono
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

4.  Role of NKG2D in cytokine-induced killer cells against lung cancer.

Authors:  Xiaowei Yin; Xuzhang Lu; Zhang Xiuwen; Zhou Min; Rong Xiao; Zhengdao Mao; Qian Zhang
Journal:  Oncol Lett       Date:  2017-03-03       Impact factor: 2.967

5.  Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.

Authors:  Gordana Konjevic; Ana Vuletic; Katarina Mirjacic Martinovic; Ana Krivokuca; Radmila Jankovic; Nada Babovic
Journal:  J Membr Biol       Date:  2017-09-08       Impact factor: 1.843

6.  Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.

Authors:  Kensuke Shiraishi; Kousaku Mimura; Ley-Fang Kua; Vivien Koh; Lim Kee Siang; Shotaro Nakajima; Hideki Fujii; Asim Shabbir; Wei-Peng Yong; Jimmy So; Seiichi Takenoshita; Koji Kono
Journal:  J Gastroenterol       Date:  2016-03-22       Impact factor: 7.527

7.  Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis.

Authors:  Hangeun Kim; Sandip K Bose; Keith Meyer; Ranjit Ray
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

8.  In vitro Natural Killer Cell Immunotherapy for Medulloblastoma.

Authors:  Lucia Fernández; Raquel Portugal; Jaime Valentín; Roberto Martín; Hannah Maxwell; Marta González-Vicent; Miguel Ángel Díaz; Inmaculada de Prada; Antonio Pérez-Martínez
Journal:  Front Oncol       Date:  2013-04-19       Impact factor: 6.244

9.  Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer.

Authors:  Philippe Collery; Ahmed Mohsen; Anthony Kermagoret; Samantha Corre; Gérard Bastian; Alain Tomas; Ming Wei; François Santoni; Nadia Guerra; Didier Desmaële; Jean d'Angelo
Journal:  Invest New Drugs       Date:  2015-06-26       Impact factor: 3.850

10.  A functional mammalian display screen identifies rare antibodies that stimulate NK cell-mediated cytotoxicity.

Authors:  Emily Kang; Cigall Kadoch; James L Rubenstein; Lewis L Lanier; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.